Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio

Teva Pharmaceuticals CEO Richard Francis joins ‘Money Movers’ to discuss the company’s latest acquisition of Emalex Biosciences, their latest drug offerings, and more.